SCHEMBL22889282

SCHEMBL22889282

c1ccc(-c2ccccc2-c2nc(-c3ccc(-c4cc5ccccc5c5ccccc45)c4ccccc34)nc(-c3cccc4c3oc3ccccc34)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.44
GGPS1 O95749 1/20 0.38
ALDH1A1 P00352 5/20 0.37
KDM4E B2RXH2 4/20 0.37
RAB9A P51151 2/20 0.37
MAOB P27338 1/20 0.37
PRKDC P78527 4/20 0.36
PIK3CD O00329 1/20 0.36
PIK3CB P42338 1/20 0.36
CYP11B1 P15538 1/20 0.36
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
TYK2 P29597 1/20 0.35
PTGES2 Q9H7Z7 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPT P10636 4/20 0.35
HPGD P15428 3/20 0.35
TSHR P16473 3/20 0.35
HSD17B10 Q99714 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22888826 0.95 ALOX5 (0.45) ALOX5GGPS1ALDH1A1KDM4ERAB9A
SCHEMBL22889378 0.93 ALOX5 (0.44) ALOX5GGPS1ALDH1A1KDM4ERAB9A
SCHEMBL22889399 0.92 ALOX5 (0.41) ALOX5GGPS1ALDH1A1KDM4ERAB9A
SCHEMBL22888915 0.92 ALOX5 (0.41) ALOX5GGPS1ALDH1A1KDM4ERAB9A
SCHEMBL22889155 0.92 ALOX5 (0.41) ALOX5GGPS1ALDH1A1KDM4ERAB9A
SCHEMBL22889283 0.91 ALOX5 (0.44) ALOX5GGPS1ALDH1A1KDM4ERAB9A
SCHEMBL22888837 0.90 ALOX5 (0.46) ALOX5GGPS1ALDH1A1KDM4EPRKDC
SCHEMBL22889253 0.90 ALOX5 (0.46) ALOX5GGPS1ALDH1A1KDM4ERAB9A
SCHEMBL22889423 0.90 ALOX5 (0.45) ALOX5GGPS1ALDH1A1KDM4ERAB9A
SCHEMBL25049768 0.90 ALOX5 (0.47) ALOX5GGPS1ALDH1A1KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, RPS4Y1, AR ALOX5 3163/4885GGPS1 3177/4885ALDH1A1 1387/4885
US-11765972-B2 Compound and organic electroluminescence device using the same AR, OR10J3, RPS4Y1 ALOX5 3071/4885GGPS1 3231/4885ALDH1A1 1441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.